AT339890B - Verfahren zur herstellung von neuen thiophen- bzw. furanderivaten und ihren salzen - Google Patents

Verfahren zur herstellung von neuen thiophen- bzw. furanderivaten und ihren salzen

Info

Publication number
AT339890B
AT339890B AT829274A AT829274A AT339890B AT 339890 B AT339890 B AT 339890B AT 829274 A AT829274 A AT 829274A AT 829274 A AT829274 A AT 829274A AT 339890 B AT339890 B AT 339890B
Authority
AT
Austria
Prior art keywords
furanderivatives
thiophen
salt
manufacturing new
manufacturing
Prior art date
Application number
AT829274A
Other languages
English (en)
Other versions
ATA829274A (de
Inventor
Germaine Dr Ing Thuillier
Jacqueline Ing Laforest
Pierre Bessin
Original Assignee
Cerpha
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Cerpha filed Critical Cerpha
Publication of ATA829274A publication Critical patent/ATA829274A/de
Application granted granted Critical
Publication of AT339890B publication Critical patent/AT339890B/de

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D295/00Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms
    • C07D295/04Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms
    • C07D295/08Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by singly bound oxygen or sulfur atoms
    • C07D295/084Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by singly bound oxygen or sulfur atoms with the ring nitrogen atoms and the oxygen or sulfur atoms attached to the same carbon chain, which is not interrupted by carbocyclic rings
    • C07D295/088Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by singly bound oxygen or sulfur atoms with the ring nitrogen atoms and the oxygen or sulfur atoms attached to the same carbon chain, which is not interrupted by carbocyclic rings to an acyclic saturated chain
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/38Heterocyclic compounds having sulfur as a ring hetero atom
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • A61P9/08Vasodilators for multiple indications
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • A61P9/10Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • A61P9/12Antihypertensives
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D307/00Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom
    • C07D307/02Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings
    • C07D307/34Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
    • C07D307/38Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with substituted hydrocarbon radicals attached to ring carbon atoms
    • C07D307/40Radicals substituted by oxygen atoms
    • C07D307/46Doubly bound oxygen atoms, or two oxygen atoms singly bound to the same carbon atom
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D307/00Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom
    • C07D307/02Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings
    • C07D307/34Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
    • C07D307/38Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with substituted hydrocarbon radicals attached to ring carbon atoms
    • C07D307/52Radicals substituted by nitrogen atoms not forming part of a nitro radical
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D307/00Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom
    • C07D307/02Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings
    • C07D307/34Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
    • C07D307/56Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D307/00Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom
    • C07D307/02Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings
    • C07D307/34Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
    • C07D307/56Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D307/70Nitro radicals
    • C07D307/71Nitro radicals attached in position 5
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D333/00Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom
    • C07D333/02Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings
    • C07D333/04Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings not substituted on the ring sulphur atom
    • C07D333/06Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings not substituted on the ring sulphur atom with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to the ring carbon atoms
    • C07D333/14Radicals substituted by singly bound hetero atoms other than halogen
    • C07D333/20Radicals substituted by singly bound hetero atoms other than halogen by nitrogen atoms
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D333/00Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom
    • C07D333/02Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings
    • C07D333/04Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings not substituted on the ring sulphur atom
    • C07D333/06Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings not substituted on the ring sulphur atom with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to the ring carbon atoms
    • C07D333/22Radicals substituted by doubly bound hetero atoms, or by two hetero atoms other than halogen singly bound to the same carbon atom
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D333/00Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom
    • C07D333/02Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings
    • C07D333/04Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings not substituted on the ring sulphur atom
    • C07D333/26Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings not substituted on the ring sulphur atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D333/28Halogen atoms
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D333/00Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom
    • C07D333/02Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings
    • C07D333/04Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings not substituted on the ring sulphur atom
    • C07D333/26Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings not substituted on the ring sulphur atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D333/42Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings not substituted on the ring sulphur atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms with nitro or nitroso radicals directly attached to ring carbon atoms
    • C07D333/44Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings not substituted on the ring sulphur atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms with nitro or nitroso radicals directly attached to ring carbon atoms attached in position 5

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Cardiology (AREA)
  • Epidemiology (AREA)
  • Urology & Nephrology (AREA)
  • Vascular Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Heterocyclic Compounds Containing Sulfur Atoms (AREA)
  • Furan Compounds (AREA)
AT829274A 1973-10-19 1974-10-16 Verfahren zur herstellung von neuen thiophen- bzw. furanderivaten und ihren salzen AT339890B (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR7337444A FR2248033B1 (de) 1973-10-19 1973-10-19

Publications (2)

Publication Number Publication Date
ATA829274A ATA829274A (de) 1977-03-15
AT339890B true AT339890B (de) 1977-11-10

Family

ID=9126699

Family Applications (1)

Application Number Title Priority Date Filing Date
AT829274A AT339890B (de) 1973-10-19 1974-10-16 Verfahren zur herstellung von neuen thiophen- bzw. furanderivaten und ihren salzen

Country Status (19)

Country Link
US (1) US4029808A (de)
JP (3) JPS50111064A (de)
AT (1) AT339890B (de)
BE (1) BE821237A (de)
CA (1) CA1064491A (de)
CH (1) CH601279A5 (de)
CS (1) CS192537B2 (de)
DD (1) DD115118A5 (de)
DE (2) DE2463088C1 (de)
FR (1) FR2248033B1 (de)
GB (1) GB1436307A (de)
HU (1) HU170388B (de)
IL (1) IL45772A (de)
NL (1) NL7412659A (de)
OA (1) OA04796A (de)
PH (1) PH12992A (de)
PL (1) PL99875B1 (de)
YU (1) YU36514B (de)
ZA (1) ZA746631B (de)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4207319A (en) * 1973-10-19 1980-06-10 Albert Rolland S.A. Thienyl or furyl phenyl O-hetero amino alkyl oximes and use thereof
US4148911A (en) * 1977-07-08 1979-04-10 Societe Anonyme Dite Albert Rolland S.A. Method of treating respiratory disorders
FR2428036A1 (fr) * 1978-06-08 1980-01-04 Rolland Sa A Nouveaux intermediaires de synthese pour la preparation de 0-(amino alkyl) oximes diaromatiques
US4246277A (en) * 1979-06-22 1981-01-20 Albert Rolland S.A. Lowering the concentration of plasma triglycerides
FR2480752A1 (fr) * 1980-04-21 1981-10-23 Cherqui Jean Nouveaux composes derives de la phenylthiazolylcetone, leur procede d'obtention et les compositions pharmaceutiques en contenant
JPS56174550U (de) * 1980-05-27 1981-12-23
DK270488D0 (da) * 1988-05-18 1988-05-18 Novo Industri As Hidtil ukendte o-substituerede ketoximer
US6268312B1 (en) * 1994-04-01 2001-07-31 Shionogi & Co., Ltd. Oxime derivative and bactericide containing the same as active ingredient
WO1995026956A1 (fr) * 1994-04-01 1995-10-12 Shionogi & Co., Ltd. Derive d'oxime et bactericide le contenant en tant qu'ingredient actif

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3084171A (en) * 1961-10-19 1963-04-02 Abbott Lab 5-nitro-2-furylamidine and alkyl 5-nitro-2-furylimidate
US3272833A (en) * 1963-10-09 1966-09-13 Abbott Lab Certain substituted 5-nitro-2-furylamidoximes
NL6810133A (de) * 1968-07-18 1970-01-20
US3895039A (en) * 1972-11-06 1975-07-15 Roussel Uclaf Carbamaldoximes

Also Published As

Publication number Publication date
CS192537B2 (en) 1979-08-31
CA1064491A (en) 1979-10-16
HU170388B (de) 1977-06-28
JPS5373556A (en) 1978-06-30
IL45772A (en) 1978-04-30
DE2463088C1 (de) 1982-07-15
JPS50111064A (en) 1975-09-01
JPS5538946B2 (de) 1980-10-07
BE821237A (fr) 1975-02-17
YU277774A (en) 1982-02-25
YU36514B (en) 1984-02-29
ZA746631B (en) 1976-02-25
AU7415574A (en) 1976-04-15
PL99875B1 (pl) 1978-08-31
NL7412659A (nl) 1975-04-22
ATA829274A (de) 1977-03-15
GB1436307A (en) 1976-05-19
IL45772A0 (en) 1974-12-31
DE2449205C2 (de) 1982-03-11
FR2248033A1 (de) 1975-05-16
US4029808A (en) 1977-06-14
PH12992A (en) 1979-10-29
OA04796A (fr) 1980-08-31
CH601279A5 (de) 1978-06-30
FR2248033B1 (de) 1977-03-11
DE2449205A1 (de) 1975-04-24
JPS5325555A (en) 1978-03-09
DD115118A5 (de) 1975-09-12

Similar Documents

Publication Publication Date Title
AT333759B (de) Verfahren zur herstellung von neuen 3-subst.-4-phenylpiperidinen und von deren salzen
AT336029B (de) Verfahren zur herstellung von neuen imidazotriazinen und ihren salzen
AT352125B (de) Verfahren zur herstellung von neuen substituierten 1,3-dihydro-spiro- (isobenzofuranen) und ihren salzen
AT331258B (de) Verfahren zur herstellung von neuen 1,2,3-oxathiazin-4-onen
AT336604B (de) Verfahren zur herstellung von neuen triazolopyridazinen und ihren salzen
ATA993573A (de) Verfahren zur herstellung von neuen cephalosporinathern
AT336008B (de) Verfahren zur herstellung von neuen imidazolyl-o,n-acetalen und ihren salzen
AT325605B (de) Verfahren zur herstellung von neuen alpha-phenylindolderivaten
AT333296B (de) Verfahren zur herstellung von neuen 7-fluor-substituierten phenthiazinen, ihren salzen und ihren piperazin-n-oxyden
AT339890B (de) Verfahren zur herstellung von neuen thiophen- bzw. furanderivaten und ihren salzen
AT331794B (de) Verfahren zur herstellung von neuen 3,4-dihydro-2h-pyran-2,4-dionen und ihren salzen
AT330955B (de) Verfahren zur herstellung von neuen beta-lactamen
AT332425B (de) Verfahren zur herstellung von neuen 6-aminouracilen und ihren salzen
AT328098B (de) Verfahren zur herstellung von neuen n-(heteroarylmethyl)-6,14-endoatheno-7alpha-hydroxyalkyl-tetrahydro-nororipavinen und -thebainen
AT334357B (de) Verfahren zur herstellung von neuen, basisch substituierten benzimidazol-abkommlingen und ihren salzen
AT325052B (de) Verfahren zur herstellung von neuen 6-azabenzo-1,5-diazepinen und ihren salzen
AT327213B (de) Verfahren zur herstellung von neuen lactamen
AT331805B (de) Verfahren zur herstellung von neuen triazinobenzimidazolen
AT325606B (de) Verfahren zur herstellung von neuen indolylalkylaminen und ihren salzen
AT334355B (de) Verfahren zur herstellung von neuen 2-aminoalkyl -3- phenyl-indolen und ihren salzen
AT333740B (de) Verfahren zur herstellung von neuen indanderivaten
AT327413B (de) Verfahren zur herstellung von neuen 15alpha,16alpha-methylen-4-ostren-17beta-olen
ATA143575A (de) Verfahren zur herstellung von neuen d-2-subst.-6-methyl-8-cyanomethylergolinen und deren salzen
AT329533B (de) Verfahren zur herstellung von neuen cyclopentanalen
AT325048B (de) Verfahren zur herstellung von neuen dihydro - 2 - aminoisochinolinen

Legal Events

Date Code Title Description
EIH Change in the person of patent owner
ELJ Ceased due to non-payment of the annual fee